Melissa Lattanzi is Vice President, Emerging Therapies for Cencora’s Strategic Global Sourcing team. She is responsible for product access, distribution strategy, and contracting and trade relations for the cell and gene therapy and biosimilar categories.

Melissa leads business development efforts and partners with companies during clinical development on distribution and channel considerations in order to ensure commercial success. She collaborates with internal teams to ensure proper processes and infrastructure are in place to meet the unique needs of this growing category, and is a key member of the cell & gene team developing Cencora’s enterprise strategy.

Melissa joined Cencora (then AmerisourceBergen) in 2005 and has held a variety of positions spanning retail programs, full line wholesale and specialty distribution relations, channel strategy & commercialization services.